(Use Google Chrome or Mozilla Firefox to secure your place)

16 October 2019 | Online | Free-to-attend

Simplifying Global Complexity:
The Role of AI from Licensing to Regulatory Compliance

Without a refined business development and licensing process, companies would never discover the deals on which they can build their brand. And without a strong regulatory department, even the most successful drugs would fail to make it to market.

But both of these divisions are drowning in complexity. As the scope of information to manage increases and the need for continual monitoring grows, companies have to seek out innovative solutions to augment the effectiveness of their teams.

In this online event, we bring together industry experts to discuss a potentially transformative solution; artificial intelligence.

SESSION 1 :
Using AI and Competitive Intelligence for portfolio prioritization and evaluating external assets 

2pm-2:45pm [BST] 

SESSION 2 :
Winning in global regulatory with AI: Advancing compliance, increasing approval rates and simplifying market expansion

3pm-3:45pm [BST]

SESSION 3 :
Simplifying the drug life-cycle: Bringing it all together

4pm-4:45pm [BST]